[go: up one dir, main page]

LT2780003T - Antinksčių nepakankamumo gydymas - Google Patents

Antinksčių nepakankamumo gydymas

Info

Publication number
LT2780003T
LT2780003T LTEP12806617.2T LT12806617T LT2780003T LT 2780003 T LT2780003 T LT 2780003T LT 12806617 T LT12806617 T LT 12806617T LT 2780003 T LT2780003 T LT 2780003T
Authority
LT
Lithuania
Prior art keywords
treatment
adult disease
adult
disease
Prior art date
Application number
LTEP12806617.2T
Other languages
English (en)
Inventor
Hiep Huatan
Richard Ross
Martin Whitaker
Original Assignee
Diurnal Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Limited filed Critical Diurnal Limited
Publication of LT2780003T publication Critical patent/LT2780003T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
LTEP12806617.2T 2011-11-19 2012-11-19 Antinksčių nepakankamumo gydymas LT2780003T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1119985.8A GB201119985D0 (en) 2011-11-19 2011-11-19 Treatment of adrenal insufficiency
PCT/GB2012/052864 WO2013072707A1 (en) 2011-11-19 2012-11-19 Treatment of adrenal insufficiency

Publications (1)

Publication Number Publication Date
LT2780003T true LT2780003T (lt) 2020-04-27

Family

ID=45475414

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP12806617.2T LT2780003T (lt) 2011-11-19 2012-11-19 Antinksčių nepakankamumo gydymas

Country Status (22)

Country Link
US (2) US9675559B2 (lt)
EP (1) EP2780003B1 (lt)
JP (2) JP6228125B2 (lt)
KR (1) KR101995999B1 (lt)
AU (1) AU2012338583B2 (lt)
BR (1) BR112014011745B1 (lt)
CA (1) CA2854717C (lt)
CY (1) CY1123130T1 (lt)
DK (1) DK2780003T3 (lt)
ES (1) ES2782503T3 (lt)
GB (2) GB201119985D0 (lt)
HR (1) HRP20200452T1 (lt)
HU (1) HUE048445T2 (lt)
IL (1) IL232065A (lt)
LT (1) LT2780003T (lt)
PL (1) PL2780003T3 (lt)
PT (1) PT2780003T (lt)
RS (1) RS60132B1 (lt)
SI (1) SI2780003T1 (lt)
SM (1) SMT202000230T1 (lt)
WO (1) WO2013072707A1 (lt)
ZA (1) ZA201403462B (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
KR102186095B1 (ko) 2018-05-14 2020-12-03 주식회사 엘지화학 화합물 및 이를 포함하는 유기 발광 소자
US11904046B1 (en) 2022-11-14 2024-02-20 Eton Pharmaceuticals, Inc. Hydrocortisone oral liquid formulations
WO2025240605A1 (en) 2024-05-15 2025-11-20 Neurocrine Biosciences, Inc. Combination treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183662A (en) 1990-08-30 1993-02-02 Senju Pharmaceutical Co., Ltd. Controlled drug release composition
KR19990077278A (ko) * 1996-01-16 1999-10-25 마이클 오코넬 약물의 하부 위장관으로의 국소적 전달
CA2277017C (en) * 1997-01-06 2002-11-26 Pfizer Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
MXPA06012088A (es) 2004-04-22 2007-08-14 Duocort Ab Composiciones farmaceuticas para terapia aguda con glucocorticoides.
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
RU2382637C2 (ru) 2004-04-30 2010-02-27 Астеллас Фарма Инк. Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию
US20070281007A1 (en) 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
WO2008126076A2 (en) 2007-04-11 2008-10-23 Perrigo Israel Pharmaceuticals Ltd. Low-dose mometasone formulations
JP5461179B2 (ja) * 2007-06-06 2014-04-02 旭化成ケミカルズ株式会社 セルロース系微小核粒子及びその製造方法
GB0817120D0 (en) 2008-09-19 2008-10-29 Diurnal Ltd Treatment of adrenal insufficiency
CA2757858C (en) 2009-04-07 2017-03-28 Duocort Pharma Ab Improved glucocorticoid therapy
JP5758899B2 (ja) * 2009-09-17 2015-08-05 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se 活性物質を含有するコーティングにより被覆されたペレット
JP2013526552A (ja) 2010-05-20 2013-06-24 デュオコート・ファーマ・アクチボラゲット グルココルチコイドベース組成物の薬量学および新規な投与方法
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition

Also Published As

Publication number Publication date
KR101995999B1 (ko) 2019-07-03
SMT202000230T1 (it) 2020-07-08
ZA201403462B (en) 2016-05-25
US20140287052A1 (en) 2014-09-25
US20170202856A1 (en) 2017-07-20
GB2509663B (en) 2015-01-07
GB201119985D0 (en) 2012-01-04
EP2780003B1 (en) 2020-02-19
JP6228125B2 (ja) 2017-11-08
HK1194005A1 (en) 2014-10-10
US9675559B2 (en) 2017-06-13
CA2854717C (en) 2020-12-08
DK2780003T3 (da) 2020-03-30
ES2782503T3 (es) 2020-09-15
IL232065A0 (en) 2014-05-28
PT2780003T (pt) 2020-04-08
JP2014533679A (ja) 2014-12-15
KR20140108638A (ko) 2014-09-12
CY1123130T1 (el) 2021-10-29
SI2780003T1 (sl) 2020-07-31
IL232065A (en) 2016-04-21
AU2012338583A1 (en) 2014-05-01
US9717740B1 (en) 2017-08-01
PL2780003T3 (pl) 2020-06-29
CA2854717A1 (en) 2013-05-23
HRP20200452T1 (hr) 2020-10-16
HUE048445T2 (hu) 2020-08-28
BR112014011745B1 (pt) 2022-04-05
WO2013072707A1 (en) 2013-05-23
RS60132B1 (sr) 2020-05-29
BR112014011745A2 (pt) 2017-05-30
JP2017200942A (ja) 2017-11-09
EP2780003A1 (en) 2014-09-24
AU2012338583B2 (en) 2017-01-19
GB201407380D0 (en) 2014-06-11
GB2509663A (en) 2014-07-09

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
LT2885010T (lt) Tautopatijos gydymo būdai
HUE048876T2 (hu) Rákos megbetegedések kezelése
PL2739153T3 (pl) Leczenie raka sutka
HUE043171T2 (hu) Neurodegeneratív betegségek kezelésére hasznos 1-arilkarbonil-4-oxi-piperidinvegyületek
EP2670434A4 (en) TREATMENT OF TAUOPATHIES
EP2684546A4 (en) Disposable diaper
EP2715491A4 (en) RAND GESTURE
HUE053247T2 (hu) Mieloszuppresszió kezelése
IL229017B (en) Oxidative retinal diseases
HUE037660T2 (hu) Androgén készítmény szembetegség kezelésére
IL231092A0 (en) Treatment of rhinitis
HRP20180962T1 (hr) Liječenje bolesti zgrušavanja primjenom rekombinantnog vwf
BR112014015814A2 (pt) fralda descartável
EP2750709A4 (en) TREATMENT OF KACHEXIE
EP2694107A4 (en) TREATMENT OF DERMATOLOGICAL SUFFERING
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
BR112014012223A2 (pt) fralda descartável
IL229081A0 (en) Isoxazolines as therapeutic agents
DK2673363T3 (da) Behandling af angiogenesesygdomme
CO6880064A2 (es) Métodos terapéuticos
LT2780003T (lt) Antinksčių nepakankamumo gydymas
PL3447070T3 (pl) Związki do leczenia blokady mielinizacji w chorobach związanych z ekspresją białka otoczki herv-w
BR112014012225A2 (pt) fralda descartável